subtweet: people with ostensibly successful careers telling undergrads not to do a PhD is gatekeeping. It’s quite hard to predict what your future job needs. Do a doctoral if you can have sustained interest in a topic for 5-6 years.

WOW! Direct and Detailed Site-Specific Glycopeptide Characterization by Higher-Energy Electron-Activated Dissociation Tandem Mass Spectrometry | Analytical Chemistry pubs.acs.org/doi/10.1021/ac…

Exciting news from the Schatton and Barthel Labs at Brigham and Women's Hospital Harvard Medical School! Our study on Merkel cell carcinoma growth and PD-1 has been published. Congratulations to Christina Martins, and the entire team. science.org/doi/10.1126/sc…

Why are women so much more susceptible to autoimmune diseases than men? A new explanation for the discrepancy has emerged go.nature.com/3Uu3kXf

1/11 My good deed for the week. A 🧵 Halfway through my endo list yesterday the DSU nurse came in. “The last patient's arrived with his mother. He’s autistic and says he gets seizures when he is overstimulated.” She handed me his file. “There’s a letter from the neurologist”.

Don’t let others determine your trajectory. I still remember being told early on I would not be able to get through engineering. Glad this wasn’t the case!

The U.S. FDA has granted accelerated approval for our therapy for advanced melanoma. Learn more: ir.iovance.com/news-releases/…

Alright folks, we’ve split our project scientist job ad into two open roles Arcadia Science. One for discovery project scientists developing platform tools to more effectively mine the tree of life and the other for scientist entrepreneurs that will run translational pilots for

At #AACR2024, I will present our scientific findings on the cancer immune function of #IGSF8, a fascinating gene which is like the PDL1 for the innate immune system. Hope to catch up with many colleagues at #AACR! prnewswire.com/news-releases/…

Reposting my offer: 1-1 mentoring by phone on anything science/career related! Have talked to undergrads to tenured faculty and everything in between. Email me to find a time. As always, very happy to chat with people from diverse backgrounds.

Check out our latest review online today Nature Reviews Cancer - we synthesize the lymphatic vessel literature in the context of the rapidly evolving field of cancer immunotherapy Triantafyllia #TennyM Perlmutter Cancer Center at NYU Langone Health NYU Grossman School of Medicine rdcu.be/dEswn

On Monday, I had further experimental treatment for my “brain cancer” #glioblastoma. This was delayed because there had been concerns about some of my blood test results. As a consequence, until recently, I hadn’t been exercising. But I am continuing to feel well. Thank you

We celebrate the holiday...by providing you with an updated comprehensive list of POSTDOC fellowships. For each of the 312 entries, we provide a description to of the fellowship, deadline, $ amount, and eligibility criteria. Good luck! Download it here: research.jhu.edu/rdt/funding-op…

Exciting new inroads into human biology and therapy development: Human intestinal organoids with an autologous tissue-resident immune compartment! #Gjorevski #Cabon #IHB nature Institute of Human Biology nature.com/articles/s4158…

Astonishing breakthrough in #organoid engineering, as reported in nature by T Recaldin,M Harter,L Steinacher,B Gjeta, and colleagues: intestinal epithelial organoids incorporating tissue-resident immune cells. Institute of Human Biology Roche go.roche.com/4a5t1

1) Excited to share a ms entitled: Integrin-activating Yersinia protein Invasin sustains long-term expansion of primary epithelial cells as 2D #organoid sheets. It describes an alternative to #Matrigel biorxiv.org/cgi/content/sh… A thread: